Connect Sign In
ARUP researchers and medical directors will join industry leaders at AACC 2023 to share their expertise on laboratory stewardship, workforce needs, automation, and more.
ARUP Laboratories has received FDA approval for its companion diagnostic immunoassay, AAV5 DetectCDx™, which helps determine patient eligibility for a new gene therapy for severe hemophilia A.
The Utah Worksite Wellness Council recently honored ARUP for its exceptional health and wellness programs with two awards.
Jonathan Genzen, MD, PhD, Sandy Richman, MBA, C(ASCP), and Sumie Edwards, MLS(ASCP)CM, will join leaders at the Executive War College conference April 25–27 to offer guidance on lab management.
ARUP and Gestalt Diagnostics announced a partnership under which ARUP will adopt Gestalt’s PathFlow® platform as a foundation for future digital pathology initiatives.
The Spring 2023 edition of Magnify: The Art and Science of Diagnostic Medicine, is now available online and explores the legacy and future of transfusion medicine at ARUP.
Data from the 2022 Client Satisfaction Survey shows that an overwhelming majority of our clients view ARUP favorably and would recommend ARUP to colleagues.
ARUP has been selected as one of 100 Utah Companies Championing Women by In Utah, an initiative of the Utah Governor’s Office of Economic Opportunity and the Utah Women and Leadership Project.
In 2022, ARUP employees contributed $81,935 to charitable causes, an annual act of service that supports both the patients and broader communities we serve.
Laboratory-developed tests made up only about 4% of an academic health system’s total test orders in 2021, yet they played an important role in patient care, a new study shows.
